Exicure (XCUR) Research & Development (2016 - 2026)
Exicure (XCUR) reported Research & Development of $312000.0 for Q1 2026, down 61.39% on a YoY basis from $808000.0 in Q1 2025, and down 52.37% quarter-over-quarter from $655000.0 in Q4 2025.
Exicure (XCUR) Research & Development (2016 - 2026) Analysis & Trends
Exicure has reported Research & Development for 10 years, with the latest figure at $312000.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 61.39% year-over-year to $312000.0; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (up 245.3% YoY), and the FY2025 full-year result was $3.3 million, changed N/A from the prior year.
- Research & Development for Q1 2026 stood at $312000.0, down from $655000.0 in the prior quarter.
- The five-year high for Research & Development was $7.1 million in Q1 2022, with the low at $312000.0 in Q1 2026.
- Historically, Research & Development has averaged $2.5 million across 4 years, with a median of $1.0 million in 2022.
- The largest YoY upside for Research & Development was 30.42% in 2022 against a maximum downside of 90.6% in 2022.
- Exicure's Research & Development stood at $1.1 million in 2022, then surged by 32.62% to $1.4 million in 2023, then sank by 53.97% to $655000.0 in 2025, then plunged by 52.37% to $312000.0 in 2026.
- The last three Research & Development figures came in at $312000.0 (Q1 2026), $655000.0 (Q4 2025), and $888000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -58.00 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 312,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 312,000.00 |
| Dec 31, 2025 | 655,000.00 |
| Sep 30, 2025 | 888,000.00 |
| Jun 30, 2025 | 935,000.00 |
| Mar 31, 2025 | 808,000.00 |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 4.81 Mn |
| Jun 30, 2022 | 6.75 Mn |
| Mar 31, 2022 | 7.14 Mn |
| Dec 31, 2021 | 11.42 Mn |
| Sep 30, 2021 | 16.46 Mn |
| Jun 30, 2021 | 10.84 Mn |
| Mar 31, 2021 | 10.26 Mn |
| Dec 31, 2020 | 3.75 Mn |
| Sep 30, 2020 | 9.14 Mn |
| Jun 30, 2020 | 7.01 Mn |
| Mar 31, 2020 | 6.08 Mn |
| Dec 31, 2019 | 8.27 Mn |
| Sep 30, 2019 | 4.25 Mn |